ViewRay Announces 510(k) Pending Status Of Newest Generation Of MRIdian Innovations
ViewRay, Inc. (NASDAQ:VRAY) today announced that the company has received acceptance from the FDA on their recent submission for new MRIdian features focused on enhancing on-table adaptive workflow efficiency and
8 Health Care Stocks With Unusual Options Alerts In Today’s Session
This unusual options alert can help traders discover the next big trading opportunities. Traders will search for circumstances when the market estimation of an option diverges heavily from its normal worth. Unusual trading activity could push option prices to exaggerated or underestimated levels.
Return on Capital Employed Overview: ViewRay
After pulling data from Benzinga Pro it seems like during Q2, ViewRay (NASDAQ:VRAY) brought in sales totaling $15.03 million. However, earnings decreased 7.34%, resulting in a loss of $26.48 million.
ViewRay Announces Amsterdam University Medical Centers Has Begun Using MRIdian SMART
ViewRay, Inc. (NASDAQ:VRAY) today announced that the clinical team at Amsterdam University Medical Centers (Amsterdam UMC) has started offering "same-day ablative treatment" using MRIdian SMART
ViewRay Announced UCLA Health Treated its 1,000th Patient Using MRIdian MRI-Guided Radiation Therapy
ViewRay, Inc. (NASDAQ: VRAY) today announced that UCLA Health joins the Siteman Cancer Center at Washington University, Seoul National University Hospital and Amsterdam UMC in surpassing the treatment of 1,000 patients using the MRIdian® MRI-guided radiation therapy system.
